1. Home
  2. KNSA vs GB Comparison

KNSA vs GB Comparison

Compare KNSA & GB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • GB
  • Stock Information
  • Founded
  • KNSA 2015
  • GB 1980
  • Country
  • KNSA United Kingdom
  • GB Switzerland
  • Employees
  • KNSA N/A
  • GB N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • GB EDP Services
  • Sector
  • KNSA Health Care
  • GB Technology
  • Exchange
  • KNSA Nasdaq
  • GB Nasdaq
  • Market Cap
  • KNSA 1.4B
  • GB 1.3B
  • IPO Year
  • KNSA 2018
  • GB N/A
  • Fundamental
  • Price
  • KNSA $20.02
  • GB $7.31
  • Analyst Decision
  • KNSA Strong Buy
  • GB Buy
  • Analyst Count
  • KNSA 5
  • GB 1
  • Target Price
  • KNSA $36.60
  • GB $6.00
  • AVG Volume (30 Days)
  • KNSA 567.6K
  • GB 1.3M
  • Earning Date
  • KNSA 02-25-2025
  • GB 02-26-2025
  • Dividend Yield
  • KNSA N/A
  • GB N/A
  • EPS Growth
  • KNSA N/A
  • GB 422.66
  • EPS
  • KNSA N/A
  • GB 0.21
  • Revenue
  • KNSA $384,098,000.00
  • GB $517,909,882.00
  • Revenue This Year
  • KNSA $60.10
  • GB $21.30
  • Revenue Next Year
  • KNSA $34.22
  • GB $11.47
  • P/E Ratio
  • KNSA N/A
  • GB $34.90
  • Revenue Growth
  • KNSA 54.41
  • GB 21.84
  • 52 Week Low
  • KNSA $16.56
  • GB $4.26
  • 52 Week High
  • KNSA $28.15
  • GB $8.00
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 53.15
  • GB 58.39
  • Support Level
  • KNSA $19.31
  • GB $7.29
  • Resistance Level
  • KNSA $20.20
  • GB $7.36
  • Average True Range (ATR)
  • KNSA 0.80
  • GB 0.34
  • MACD
  • KNSA 0.06
  • GB 0.06
  • Stochastic Oscillator
  • KNSA 72.80
  • GB 95.97

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About GB Global Blue Group Holding AG

Global Blue Group Holding AG offers a seamless shopping and payment journey for tourists and also provides a wide range of Added-Value Payment Solutions for all the stakeholders involved, including retailers and international shoppers. The company connect thousands of retailers, acquirers, and hotels with nearly 80 million consumers across more than 50 countries, in three industries: Tax Free Shopping, Payments and Post-Purchase solutions.

Share on Social Networks: